InsideArbitrage Event Driven Monitor – April 7, 2026

Note: You can click on any section title to jump straight to the related tool or page.

SLNO: The acquisition of Soleno Therapeutics, Inc. (SLNO) by Neurocrine Biosciences, Inc. (NBIX) for a closing value of $2.9 billion. Neurocrine, through a subsidiary, will commence a cash tender offer to acquire all of the outstanding shares of Soleno’s common stock for $53 per share, representing a premium of 34.21% from the stock’s last close. (Press Release)
CCO: Clear Channel Outdoor (CCO) announced that it has commenced a consent solicitation for its outstanding senior secured notes, consisting of $865 million aggregate principal amount of 7.875% Senior Secured Notes due 2030; $1.15 billion aggregate principal amount of 7.125% Senior Secured Notes due 2031; and $900 million aggregate principal amount of 7.5% Senior Secured Notes due 2033, to approve certain Proposed Amendments to the indentures governing the Senior Secured Notes. The consent solicitation is scheduled to expire on April 10, 2026.
HOLX: Hologic (HOLX) announced that CEO Steve MacMillan has decided to retire when the company’s go-private deal with Blackstone (BX) and TPG (TPG) closes. All required regulatory approvals have now been received for the deal, which is expected to close on April 7, 2026.

Only plus or premium subscribers can access this post. Subscribe today.

Subscribe Today